Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
BBTX · NASDAQ · Biological Products, (No Diagnostic Substances) · No 10-K yet
Bambusa Therapeutics (BBTX) · oqro.io/stocks/BBTX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$16.09
Close of Nov 13, 2026 · end-of-day, not a live quote
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake, activist · Stake as of Oct 30, 2026 · Filed Nov 6, 2026
RA Capital Management, L.P. disclosed a 14.6% stake in BBTX and may seek to influence the companySource5%+ stake · Stake as of Oct 29, 2026 · Filed Nov 5, 2026
Thomas Maier now owns 9.2% of BBTX as a passive investorSourceInsider trade · Traded Nov 2, 2026 · Filed Nov 3, 2026
Director purchased ~$37.4M of BBTX shares in the open marketSourceInsider trade · Traded Oct 30, 2026 · Filed Nov 3, 2026
Director purchased ~$3.94M of BBTX shares in the open marketSourceInsider trade · Traded Oct 30, 2026 · Filed Nov 3, 2026
Director purchased ~$2.7M of BBTX shares in the open marketSourceInsider trade · Traded Nov 2, 2026 · Filed Nov 3, 2026
Director purchased ~$2.64M of BBTX shares in the open marketSourceInsider trade · Traded Nov 2, 2026 · Filed Nov 2, 2026
10% owner purchased ~$6M of BBTX shares in the open marketSourceInsider trade · Traded Nov 2, 2026 · Filed Nov 2, 2026
Director purchased ~$6M of BBTX shares in the open marketSource